BioRegion Real Estate | GenomeWeb

BioRegion Real Estate

Premium

Sanofi-aventis Kicks Off €200M Conversion of French Pharma Plant into Biotech Facility

Sanofi-aventis said this week it will spend €200M ($266 million) to transform its pharmaceuticals production site in Vitry-sur-Seine, France, into a facility for researching, developing, then producing biotechnology products through alliances with smaller biotech companies. Starting in 2012, for example, the plant is expected to create the company’s first cell culture biotechnoloy platform designed to produce monoclonal antibodies.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Browse our free articles
You can still register for access to our free content.

In Science this week: new single-cell RNA sequencing technique to study proliferating cells, and more.

South African researchers uncover bone cancer in an ancient hominin ancestor.

English bulldogs suffer from low genetic diversity and might have to be outbred to improve their health, according to a new study.

Theresa May tries to reassure researchers about the UK's commitment to science, New Scientist reports.